Form 1 2019 NCORP Annual Meeting Assessment

2019 NCORP Annual Meeting
OMB No.: 0925-0642
Expiration Date: 5/31/2020

Public reporting burden for this collection of information is estimated to average 10 minutes per response, including the time
for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and
reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a
collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden
estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: NIH, Project
Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0642). Do not return
the completed form to this address.

2019 NCORP Annual Meeting
General Questions

Please select the best response for each question.

1. What is your role in NCORP? (Check all that apply)
PI or Investigator

Clinical / Research Staff

NCORP Administrator

Disparities Integration Lead

CCDR Lead

NCI Staff

Other (please specify)

2. What type of NCORP grantee do you represent?
Community Site

Research Base

Minority/Underserved Community Site

Not Applicable

1

3. Did you attend the NCORP Administrators' Meeting? (If no, skip to
question 8)
Yes
No

2019 NCORP Annual Meeting
NCORP Administrators' Meeting - August 21, 2019

For each session, please select the response which best represents the extent to which you agree or disagree with the
statements below (Administrators' Meeting attendees only).

4. The following sessions provided useful information for my NCORP
role.
Agree

Neutral

Disagree

NCORP Guidelines: A
Brief Overview
Unique Characteristics of
NCORP: Cancer Control,
Prevention, Screening,
CCDR & Disparities
NIH Grant Process Managing an NIH Grant
"Seasoned" NCORP
Administrators Panel
RCR and DTL Overview
NCORP-SYS and NCORP
Portal Overview
NCORP Research Base
Administrators Panel
Comments

2

5. Was the length of the Administrators' Meeting?
Too long
Just right
Too short

6. Overall, how would you rate the Administrators' Meeting?
Excellent
Good
Fair
Poor

7. Any additional feedback on the Administrators' Meeting sessions (e.g.
sessions you found most useful, other topics you would like to see
covered, recommended improvements or changes, etc.)?

2019 NCORP Annual Meeting
Day 1 - Thursday, August 22 2019

For each session, please select the response which best represents the extent to which you agree or disagree with the
statements below.

3

8. The following sessions (titles and presenters below) provided useful
information for my NCORP role.
Agree

Neutral

Disagree

NCORP Year in Review
(Worta McCaskill-Stevens,
MD, MS)
CTEP Update (Meg
Mooney, MD)
Keynote (Andy Kolb, MD)
Cancer Care Delivery
Research: The Journey to
2025 (Ann Geiger, PhD,
MPH)
Scientific Session #1**
(Deborah K Mayer, PHD,
RN, AOCN, FAAN)
AYAs and Clinical Trials:
Are all AYAs created
equal? (Panel
Presentation)
NCORP Community Town
Hall (Daniel Anderson,
MD, and Lisa Bailey, MD)
Comments

4

9. The breakout session provided useful information for my NCORP role
(respond only for the breakout session you attended).
N/A: DID NOT ATTEND

Agree

Neutral

Disagree

Research Base PI
Session
Setting Benchmarks for
NCORP Disparities
Integration
NCORP Building
Blocks: Clinical Trial
Office Functions and Staff
Infrastructure Models
Achieving an NCORP
Priority: Enrolling
Adolescent and Young
Adult (AYA) Patients on
NCI Clinical Trials
Comments

10. Any additional feedback on the Day 1 plenary or breakout sessions?

2019 NCORP Annual Meeting
Day 2 - Friday August 23 2019

For each session, please select the response which best represents the extent to which you agree or disagree with the
statements below.

5

11. The following sessions (titles and presenters below) provided useful
information for my NCORP role.
Agree

Neutral

Disagree

NCI Director’s Remarks
(Douglas R Lowy, MD)
Updates on Broadening
Eligibility Criteria in
Cancer Clinical Trials:
Current Progress and
Future Plans (Edward
Kim, MD)
Legacy of Geriatric
Oncology (Lodovico
Balducci, MD)
Past, Present and Future
Opportunities for Geriatric
Oncology in NCORP
A New Look at How
Communications Supports
NCORP (Peter Garrett,
Director, NCI Office of
Communication & Public
Liaison)
NCI Biorepository
Initiatives in NCORP
(Helen Moore, PhD)
Comments

12. The breakout session provided useful information for my NCORP
role (respond only for the breakout you attended).
N/A: DID NOT ATTEND

Agree

Neutral

Disagree

Community and
Minority/Underserved Site
PI Session
Accrual Planning and
Opportunities within
NCORP
Being Audit Ready: Trials,
Tribulations and Triumphs
Cancer Care Delivery
Research: The Journey to
2025
Comments

6

13. Any additional feedback on the Day 2 plenary or breakout sessions?

2019 NCORP Annual Meeting
Overall Meeting

Please select the response which best represents the extent to which you agree or disagree with the statements below.

14. There was sufficient time to interact with my colleagues.
Agree

Neutral

Disagree

15. There was sufficient time to interact with NCI staff.
Agree

Neutral

Disagree

16. There was sufficient time for audience questions and dialogue on
session topics.
Agree

Neutral

Disagree

17. Was the length of the NCORP Annual Meeting?
Too long
Just right
Too short

7

18. Overall, how would you rate this NCORP Annual Meeting?
Excellent
Good
Fair
Poor

19. What session(s) did you find most useful for your role in NCORP?

20. What were the most important takeaways for you from the meeting?

21. What improvements or changes would you recommend for future
NCORP Annual meetings?

22. What other topics would you like to see covered in future annual
meetings or webinars?

8